Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Pliant Therapeutics
PLRX
$64.4M
| $313K | ﹤0.01% |
11,781
-14,734
| -56% | -$419K |
|
3452
Navigator Holdings
NVGS
$1.38B
| $313K | ﹤0.01% |
22,352
+1,844
| +9% | +$23.9K |
|
|
CANO.WS
3453
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
| $313K | ﹤0.01% |
1,955,573
+874,102
| +81% | +$258K |
|
3454
Zumiez
ZUMZ
$332M
| $311K | ﹤0.01% |
16,875
-7,327
| -30% | -$169K |
|
3455
Radiant Logistics
RLGT
$386M
| $311K | ﹤0.01% |
47,360
+8,747
| +23% | +$48.9K |
|
3456
CALL
Hilton Worldwide
HLT
$72.1B
| $310K | ﹤0.01% |
2,200
-6,200
| -74% | -$873K |
|
3457
Ardmore Shipping
ASC
$710M
| $309K | ﹤0.01% |
20,767
+5,648
| +37% | +$88.7K |
|
3458
Anterix
ATEX
$1.81B
| $308K | ﹤0.01% |
9,312
+4,368
| +88% | +$143K |
|
3459
Immersion
IMMR
$251M
| $306K | ﹤0.01% |
+34,231
| New | +$259K |
|
3460
Safe Bulkers
SB
$795M
| $305K | ﹤0.01% |
82,701
+17,092
| +26% | +$57.4K |
|
3461
Clearfield
CLFD
$411M
| $304K | ﹤0.01% |
6,535
+971
| +17% | +$62.6K |
|
|
TBRG
3462
DELISTED
TruBridge
TBRG
| $304K | ﹤0.01% |
10,062
+3,235
| +47% | +$94.2K |
|
|
SGEN
3463
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $304K | ﹤0.01% |
+1,500
| New | +$241K |
|
3464
Credit Acceptance
CACC
$5.95B
| $303K | ﹤0.01% |
696
+124
| +22% | +$54.5K |
|
3465
Silvercrest Asset Management
SAMG
$79M
| $303K | ﹤0.01% |
16,685
+2,307
| +16% | +$41.7K |
|
|
ME
3466
DELISTED
23andMe Holding Co
ME
| $302K | ﹤0.01% |
6,634
+3,064
| +86% | +$148K |
|
3467
PubMatic
PUBM
$585M
| $302K | ﹤0.01% |
21,847
+10,251
| +88% | +$148K |
|
|
EBIX
3468
DELISTED
Ebix Inc
EBIX
| $301K | ﹤0.01% |
22,833
+426
| +2% | +$7.41K |
|
3469
MediciNova
MNOV
$65.5M
| $300K | ﹤0.01% |
139,100
-9,300
| -6% | -$21.3K |
|
|
KE
3470
Kimball Electronics
KE
$595M
| $300K | ﹤0.01% |
12,464
+6,026
| +94% | +$147K |
|
3471
Dole
DOLE
$1.35B
| $300K | ﹤0.01% |
25,570
| – | – |
|
3472
Opko Health
OPK
$985M
| $299K | ﹤0.01% |
205,070
+96,664
| +89% | +$124K |
|
3473
Lightwave Logic
LWLG
$995M
| $299K | ﹤0.01% |
57,194
+26,860
| +89% | +$150K |
|
3474
BRC Group Holdings
RILY
$288M
| $298K | ﹤0.01% |
10,511
-2,210
| -17% | -$83.7K |
|
|
NKLA
3475
DELISTED
Nikola Corporation Common Stock
NKLA
| $298K | ﹤0.01% |
8,207
+3,081
| +60% | +$202K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.